Valacyclovir works by blocking the herpes simplex virus from copying its own DNA, which stops the virus from multiplying inside your cells. It’s a prodrug, meaning your body converts it into its active form (acyclovir) after you swallow it. This conversion happens rapidly in your gut and liver, and the result is blood levels of acyclovir three to five times higher than you’d get from taking acyclovir directly as a pill. That improved absorption is the entire reason valacyclovir exists.
How It Stops the Virus From Replicating
Cold sores are caused by herpes simplex virus type 1 (HSV-1), which replicates by hijacking your cells’ machinery to copy its DNA. Valacyclovir disrupts this process in two steps, both of which exploit the virus’s own biology.
First, the virus produces a specific enzyme inside infected cells. This enzyme activates the drug by converting it into a form that resembles one of the building blocks of DNA. Healthy, uninfected cells don’t have this enzyme in significant amounts, so the drug stays mostly inactive in normal tissue. This selectivity is why valacyclovir causes relatively few side effects.
Second, once activated, the drug gets incorporated into the growing chain of viral DNA. But because its chemical structure is incomplete compared to a real DNA building block, it acts like a dead end. The viral DNA chain can’t continue growing, and replication stalls. The virus can’t make new copies of itself, so the infection stops spreading to neighboring cells.
Why Timing Matters So Much
Valacyclovir only works on virus that is actively replicating. It can’t eliminate virus that’s sitting dormant in nerve cells, which is where HSV-1 hides between outbreaks. This means the drug is most effective when you take it early, before the virus has had time to replicate widely and cause significant tissue damage.
The CDC recommends starting treatment within one day of lesion onset, or ideally during the prodrome stage, that tingling, burning, or itching sensation many people feel before a blister appears. If you wait until a full blister has formed and begun to crust over, the virus has already done most of its damage and the drug has less replication left to block.
In clinical trials submitted to the FDA, people who took valacyclovir at the first sign of a cold sore had episodes that lasted about one day shorter than those who took a placebo. One day may not sound dramatic, but cold sore episodes typically run five to ten days, so shaving a day off represents a meaningful difference, especially when it also reduces pain and the size of the sore.
What Happens After You Swallow the Pill
Your body converts valacyclovir into acyclovir almost immediately. Less than 0.5% of the original drug remains as valacyclovir in your system. The absolute bioavailability of acyclovir from oral valacyclovir is about 54%, with individual values ranging from 42% to 73%. For comparison, taking acyclovir as a pill only delivers about 10% to 20% bioavailability. This higher absorption means you can take fewer doses per day and still maintain effective drug levels in your blood.
Your kidneys clear the drug, which is why staying well hydrated while taking it is important. People with kidney problems may need adjusted dosing, since the drug can accumulate if the kidneys aren’t filtering efficiently.
Reducing Viral Shedding Between Outbreaks
Even when you don’t have a visible cold sore, the virus can periodically reactivate at low levels and reach the skin surface. This is called asymptomatic shedding, and it’s one way herpes spreads between people. Valacyclovir suppresses this shedding significantly. In a randomized, placebo-controlled trial, daily valacyclovir reduced total viral shedding by 71%, subclinical (symptom-free) shedding by 58%, and shedding during active outbreaks by 64%.
That study was conducted in people with HSV-2 genital herpes, which recurs more frequently than oral HSV-1. But the underlying mechanism is the same: the drug continuously suppresses low-level viral replication, keeping the virus from reaching the surface as often.
Episodic Treatment vs. Daily Suppression
There are two ways to use valacyclovir for cold sores. Episodic treatment means you keep pills on hand and take them at the first sign of an outbreak. This approach works best for people who get cold sores a few times a year or less. The key is speed: you want to start the medication during the prodrome or within hours of noticing symptoms.
Daily suppressive therapy is the other option, where you take a lower dose every day to prevent outbreaks from happening in the first place. Suppressive therapy reduces genital herpes recurrences by 70% to 80%. For oral HSV-1, the picture is less clear. HSV-1 recurs less frequently than HSV-2 (a median of about once per year versus four times per year for HSV-2), and current data don’t show a strong benefit of chronic suppressive therapy for recurrent oral HSV-1 infections. Daily suppression is typically reserved for people who have frequent or severe outbreaks, or situations where reducing shedding is a priority.
Common Side Effects
Most people tolerate valacyclovir well. The most frequently reported side effects are headache, nausea, and stomach pain, all of which tend to be mild. Serious side effects are uncommon but can include kidney injury, particularly in people who are dehydrated or already have reduced kidney function. Signs of kidney trouble include decreased urine output and swelling in the ankles, hands, or feet.
Drinking plenty of water while taking the medication helps your kidneys process and clear the drug efficiently. This is especially relevant during short-course, higher-dose treatment for acute cold sore episodes.